Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients

Published:2005-11 Issue:11 Volume:33 Page:1275-1280
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Danet-Desnoyers Gwenn-aël H.,Luongo Jennifer L.,Bonnet Dominique A.,Domchek Susan M.,Vonderheide Robert H.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference26 articles.

1. Human telomerase and its regulation;Cong;Microbiol Mol Biol Rev,2002

2. Telomerase activation, cellular immortalization and cancer;Hahn;Ann Med,2001

3. Telomerase as a universal tumor-associated antigen for cancer immunotherapy;Vonderheide;Oncogene,2002

4. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes;Vonderheide;Immunity,1999

5. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans;Minev;Proc Natl Acad Sci U S A,2000

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04

2. Therapeutic cancer vaccination against telomerase: clinical developments in melanoma;Current Opinion in Oncology;2023-01-16

3. Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12

4. Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential;Frontiers in Immunology;2021-07-05

5. Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer;Frontiers in Immunology;2020-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3